Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
4 USD | -1,96% | -11,50% | -37,89% |
Attività
Numero di dipendenti: 467
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Chimeric Antigen Receptors T Cell Therapies
100,0
%
| 6 | 100,0 % | 2 | 100,0 % | -73,30% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
79,6
%
| - | - | 1 | 79,6 % | - |
United Kingdom
20,4
%
| - | - | 0 | 20,4 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 01/09/14 |
Chief Executive Officer | 59 | 01/10/14 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 07/08/23 |
Chief Tech/Sci/R&D Officer | - | 01/04/23 | |
David Brochu
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/19 |
Christopher Vann
COO | Chief Operating Officer | 59 | 01/10/16 |
Julia Wilson
IRC | Investor Relations Contact | - | - |
Alexander Swan
IRO | Public Communications Contact | - | 01/10/21 |
Olivia Manser
IRO | Public Communications Contact | - | 01/03/22 |
Miranda Neville
PRN | Corporate Officer/Principal | - | 01/01/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 01/08/14 |
William Young
BRD | Director/Board Member | 79 | 15/11/21 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01/03/18 |
Martin Murphy
BRD | Director/Board Member | 55 | 01/09/14 |
Chief Executive Officer | 59 | 01/10/14 | |
Linda Bain
BRD | Director/Board Member | 53 | 08/06/18 |
Robert Iannone
BRD | Director/Board Member | 57 | 20/06/23 |
Robert Azelby
BRD | Director/Board Member | 56 | 09/01 |
Martin Pulé
FOU | Founder | 51 | 01/09/14 |
Director/Board Member | 47 | 20/12 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 265 926 305 | 8 823 530 ( 3,318 %) | 0 | 3,318 % |
Coordinate società
Autolus Therapeutics Plc
The Mediaworks 191 Wood Lane
W12 7FP, London
+44 20 3829 6230
http://www.autolus.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-37,89% | 1,06 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione AUTL
- Società Autolus Therapeutics plc